Literature DB >> 11427469

HPLC assay with ultraviolet detection for therapeutic drug monitoring of sirolimus.

D C French1, M Saltzgueber, D R Hicks, A L Cowper, D W Holt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11427469

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  9 in total

1.  Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients.

Authors:  C Dansirikul; S B Duffull; R G Morris; S E Tett
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

2.  Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats.

Authors:  N Deblon; L Bourgoin; C Veyrat-Durebex; M Peyrou; M Vinciguerra; A Caillon; C Maeder; M Fournier; X Montet; F Rohner-Jeanrenaud; M Foti
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  A Bayesian approach for population pharmacokinetic modelling of sirolimus.

Authors:  Chantaratsamon Dansirikul; Raymond G Morris; Susan E Tett; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

Review 4.  Sirolimus: the evidence for clinical pharmacokinetic monitoring.

Authors:  Sunita Bond Stenton; Nilufar Partovi; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  A reversed phase high performance liquid chromatographic method for determination of rapamycin.

Authors:  Hamideh Sobhani; Alireza Shafaati; Nastaran Nafissi-Varcheh; Reza Aboofazeli
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

6.  Chronic rapamycin treatment on the nutrient utilization and metabolism of juvenile turbot (Psetta maxima).

Authors:  Qingchao Wang; Gen He; Kangsen Mai; Wei Xu; Huihui Zhou; Xuan Wang; Lin Mei
Journal:  Sci Rep       Date:  2016-06-16       Impact factor: 4.379

7.  Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method.

Authors:  Lorena Bouzas; Jesús Hermida; J Carlos Tutor
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

8.  A novel strategy inducing autophagic cell death in Burkitt's lymphoma cells with anti-CD19-targeted liposomal rapamycin.

Authors:  K Ono; T Sato; S Iyama; A Tatekoshi; A Hashimoto; Y Kamihara; H Horiguchi; S Kikuchi; Y Kawano; K Takada; T Hayashi; K Miyanishi; Y Sato; R Takimoto; M Kobune; J Kato
Journal:  Blood Cancer J       Date:  2014-02-07       Impact factor: 11.037

9.  Steady Augmentation of Anti-Osteoarthritic Actions of Rapamycin by Liposome-Encapsulation in Collaboration with Low-Intensity Pulsed Ultrasound.

Authors:  Chung-Hwan Chen; Shyh Ming Kuo; Yin-Chun Tien; Po-Chih Shen; Yi-Wen Kuo; Han Hsiang Huang
Journal:  Int J Nanomedicine       Date:  2020-05-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.